Veeva Systems Inc. (NYSE:VEEV) has seen over 100 biotech firms adopt its Veeva Basics solution, which standardizes operations across clinical, regulatory, and quality functions. The platform is built on Veeva’s Vault Platform, allowing for easy transition to a full Vault solution later. New capabilities include LIMS Basics for lab oversight and PromoMats Basics for content management.

The uptake by over 100 biotechs highlights Veeva’s growth strategy in the life sciences tools sector. The company’s cloud-software offerings cater to pharmaceutical companies and emerging biotechs, positioning it as a key player in the industry. Investors should note the company’s momentum in the emerging biotech segment.

Read more at Yahoo Finance: Veeva Expands Basics Suite as Over 100 Biotechs Adopt Platform for Scalable Growth